Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs
- PMID: 17710353
- DOI: 10.1007/s00198-007-0451-8
Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs
Abstract
We aimed to determine the effects of bisphosphonates on mechanical properties independent of changes in bone density. Our results show that at equivalent bone densities, vertebrae from beagles treated with bisphosphonate have equivalent bone strength and reduced bone energy absorption compared to those from untreated animals.
Introduction: Assessing the relationship between mechanical properties and bone density allows a biomechanical evaluation of bone quality, with differences at a given density indicative of altered quality. The purpose of this study was to evaluate the strength-density and energy absorption-density relationships in vertebral bone following a one-year treatment with clinical doses of two different bisphosphonates in beagle dogs.
Methods: Areal bone mineral density (aBMD) and compressive mechanical properties (ultimate load and energy absorption) were assessed on lumbar vertebrae from skeletally mature beagle dogs treated with vehicle (VEH), alendronate (ALN), or risedronate (RIS). Relationships among properties were assessed using analyses of covariance.
Results: Neither treatment altered the strength-density relationship compared to VEH, suggesting increases in vertebral strength with bisphosphonate-treatment are explained by increased density. The energy absorption-density relationship was altered by ALN, resulting in significantly lower energy absorption capacity at a given aBMD compared to both VEH (-22%) and RIS (-14%).
Conclusions: These data document that after adjusting for increased aBMD, vertebrae from animals treated with bisphosphonates have similar strength as those from untreated animals. Conversely, when adjusted for increased aBMD, alendronate treatment, but not risedronate treatment, significantly reduces the energy required for vertebral fracture, indicative of an alteration in bone quality.
Similar articles
-
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.Bone. 2006 Oct;39(4):872-9. doi: 10.1016/j.bone.2006.04.028. Epub 2006 Jun 12. Bone. 2006. PMID: 16765660
-
Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.J Bone Miner Res. 2007 Nov;22(11):1759-65. doi: 10.1359/jbmr.070720. J Bone Miner Res. 2007. PMID: 17663638
-
Raloxifene enhances vertebral mechanical properties independent of bone density.Bone. 2006 Nov;39(5):1130-1135. doi: 10.1016/j.bone.2006.05.007. Epub 2006 Jun 30. Bone. 2006. PMID: 16814622
-
Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.Clin Ther. 2008 Mar;30(3):443-52. doi: 10.1016/j.clinthera.2008.03.008. Clin Ther. 2008. PMID: 18405784 Review.
-
Recent Advances in Understanding Bisphosphonate Effects on Bone Mechanical Properties.Curr Osteoporos Rep. 2018 Apr;16(2):198-204. doi: 10.1007/s11914-018-0430-3. Curr Osteoporos Rep. 2018. PMID: 29497927 Free PMC article. Review.
Cited by
-
Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.PLoS One. 2017 Aug 9;12(8):e0181750. doi: 10.1371/journal.pone.0181750. eCollection 2017. PLoS One. 2017. PMID: 28793321 Free PMC article.
-
Effects of the combination treatment of raloxifene and alendronate on the biomechanical properties of vertebral bone.J Bone Miner Res. 2011 Feb;26(2):270-6. doi: 10.1002/jbmr.197. Epub 2010 Aug 4. J Bone Miner Res. 2011. PMID: 20687153 Free PMC article.
-
Effects of suppression of bone turnover on cortical and trabecular load sharing in the canine vertebral body.J Biomech. 2009 Mar 11;42(4):517-23. doi: 10.1016/j.jbiomech.2008.11.023. Epub 2009 Jan 31. J Biomech. 2009. PMID: 19181318 Free PMC article.
-
Bone microdamage: a clinical perspective.Osteoporos Int. 2009 Aug;20(8):1299-308. doi: 10.1007/s00198-009-0899-9. Epub 2009 Mar 17. Osteoporos Int. 2009. PMID: 19291343 Review.
-
Atraumatic segmental atypical femur fracture secondary to bisphosphonate use: A case report.J Clin Orthop Trauma. 2017 Aug;8(Suppl 1):S67-S71. doi: 10.1016/j.jcot.2017.03.005. Epub 2017 Mar 19. J Clin Orthop Trauma. 2017. PMID: 28878545 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical